Label: MUTIAN XRAPHCONN- drug for treatment of fip capsule

  • NDC Code(s): 73452-160-01, 73452-160-15
  • Packager: Nantong MUTIAN Biotechnology Co., Ltd
  • Category: OTC ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated December 3, 2019

If you are a consumer or patient please visit this version.

  • WARNINGS AND PRECAUTIONS

    For cats use only, Not for human use.
    Keep out of reach of children and animals.
    It is forbidden to use for cats who are allergic to the active ingredients or any excipients of this products.

  • INDICATIONS & USAGE

    For the treatment of Feline Infectious Peritonitis (FIP).
    Oral use.
    This drug is recommended for taking on an empty stomach.
    Consult your veterinarian for help in the diagnosis, treatment and control of FIP.

  • DOSAGE & ADMINISTRATION

    The daily dose for MUTIAN is 100mg/kg of body weight.

  • ACTIVE INGREDIENT

    Inotodiol

  • INACTIVE INGREDIENT

    Nicotinamide Mononucleotide
    Crocin
    S-Adenosylmethionine
    Silymarin
    Microcrystalline cellulose

  • ADVERSE REACTIONS

    In clinical studies 7 of 240 cats (about 3% of the treated cats) had vomiting associated with the use of the product.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children and animals.

  • STORAGE AND HANDLING

    Store at the room temperature.

  • PRINCIPAL DISPLAY PANEL

    Outer Package

    Outer Package

  • INGREDIENTS AND APPEARANCE
    MUTIAN XRAPHCONN 
    drug for treatment of fip capsule
    Product Information
    Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:73452-160
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    INONOTUS OBLIQUUS FRUITING BODY (UNII: MRO1FS760M) (INONOTUS OBLIQUUS FRUITING BODY - UNII:MRO1FS760M) INONOTUS OBLIQUUS FRUITING BODY10 mg  in 200 mg
    Inactive Ingredients
    Ingredient NameStrength
    NICOTINAMIDE RIBOTIDE (UNII: 2KG6QX4W0V) 30 mg  in 200 mg
    CROCIN (UNII: 877GWI46C2) 20 mg  in 200 mg
    S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (UNII: 1LM9SS1UEA) 15 mg  in 200 mg
    MILK THISTLE (UNII: U946SH95EE) 25 mg  in 200 mg
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) 100 mg  in 200 mg
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapecapsuleSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73452-160-154000 in 1 PACKAGE
    1NDC:73452-160-01200 mg in 1 CAPSULE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other12/03/2019
    Labeler - Nantong MUTIAN Biotechnology Co., Ltd (554512204)
    Registrant - Nantong MUTIAN Biotechnology Co., Ltd (554512204)
    Establishment
    NameAddressID/FEIBusiness Operations
    Nantong MUTIAN Biotechnology Co., Ltd554512204label, manufacture, api manufacture